Green Cross Corp - Asset Resilience Ratio

Latest as of September 2025: 0.14%

Green Cross Corp (006280) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩4.43 Billion
≈ $3.00 Million USD Cash + Short-term Investments

Total Assets

₩3.19 Trillion
≈ $2.16 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how Green Cross Corp's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Green Cross Corp to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Green Cross Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Green Cross Corp (006280) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩4.43 Billion 0.14%
Total Liquid Assets ₩4.43 Billion 0.14%

Asset Resilience Insights

  • Limited Liquidity: Green Cross Corp maintains only 0.14% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Green Cross Corp Industry Peers by Asset Resilience Ratio

Compare Green Cross Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 48.48%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
Drug Manufacturers - Specialty & Generic 18.70%

Annual Asset Resilience Ratio for Green Cross Corp (2003–2024)

The table below shows the annual Asset Resilience Ratio data for Green Cross Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.05% ₩1.43 Billion
≈ $970.18K
₩2.74 Trillion
≈ $1.86 Billion
-0.17pp
2023-12-31 0.22% ₩5.80 Billion
≈ $3.93 Million
₩2.64 Trillion
≈ $1.79 Billion
-0.06pp
2022-12-31 0.27% ₩6.94 Billion
≈ $4.70 Million
₩2.53 Trillion
≈ $1.71 Billion
-0.41pp
2021-12-31 0.69% ₩16.88 Billion
≈ $11.44 Million
₩2.46 Trillion
≈ $1.67 Billion
-0.39pp
2020-12-31 1.08% ₩23.21 Billion
≈ $15.73 Million
₩2.15 Trillion
≈ $1.46 Billion
-1.12pp
2019-12-31 2.20% ₩43.07 Billion
≈ $29.19 Million
₩1.96 Trillion
≈ $1.33 Billion
+1.61pp
2018-12-31 0.59% ₩10.11 Billion
≈ $6.85 Million
₩1.72 Trillion
≈ $1.17 Billion
+0.57pp
2017-12-31 0.02% ₩268.03 Million
≈ $181.64K
₩1.70 Trillion
≈ $1.15 Billion
-3.87pp
2016-12-31 3.89% ₩60.28 Billion
≈ $40.85 Million
₩1.55 Trillion
≈ $1.05 Billion
-0.04pp
2015-12-31 3.93% ₩55.58 Billion
≈ $37.67 Million
₩1.42 Trillion
≈ $959.01 Million
-0.59pp
2014-12-31 4.51% ₩60.05 Billion
≈ $40.70 Million
₩1.33 Trillion
≈ $901.56 Million
+2.75pp
2013-12-31 1.76% ₩19.43 Billion
≈ $13.16 Million
₩1.10 Trillion
≈ $748.34 Million
+1.04pp
2012-12-31 0.71% ₩6.82 Billion
≈ $4.62 Million
₩954.38 Billion
≈ $646.77 Million
-5.46pp
2011-12-31 6.17% ₩53.09 Billion
≈ $35.98 Million
₩860.35 Billion
≈ $583.05 Million
-7.78pp
2010-12-31 13.95% ₩103.44 Billion
≈ $70.10 Million
₩741.30 Billion
≈ $502.37 Million
+13.94pp
2006-12-31 0.02% ₩62.39 Million
≈ $42.28K
₩362.68 Billion
≈ $245.78 Million
-0.48pp
2005-12-31 0.50% ₩1.48 Billion
≈ $1.00 Million
₩296.73 Billion
≈ $201.09 Million
-0.30pp
2004-12-31 0.80% ₩2.00 Billion
≈ $1.35 Million
₩250.79 Billion
≈ $169.96 Million
-2.36pp
2003-12-31 3.16% ₩2.78 Billion
≈ $1.89 Million
₩88.06 Billion
≈ $59.68 Million
--
pp = percentage points

About Green Cross Corp

KO:006280 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$896.43 Million
₩1.32 Trillion KRW
Market Cap Rank
#9209 Global
#230 in Korea
Share Price
₩115900.00
Change (1 day)
+1.49%
52-Week Range
₩113200.00 - ₩180300.00
All Time High
₩493171.17
About

GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-… Read more